Table 2.
Cytogenetics of MDS Patients with or without Myelofibrosis
Cytogenetics | Myelofibrosis (Number of Cases) | p | |
---|---|---|---|
Grade 0 (n = 123, %) |
Grade 1–2 (n = 34, %) |
||
Abnormal | 68 (55.3%) | 16 (47.1%) | 0.40 |
Monosomal karyotype | 11 (8.9%) | 3 (8.8%) | 1.00 |
Complex karyotype | 8 (6.5%) | 3 (8.8%) | 0.71 |
5q- | 18 (14.6%) | 1 (2.9%) | 0.077 |
-5 | 6 (4.9%) | 0 (0%) | 0.34 |
7q- | 9 (7.3%) | 3 (8.8%) | 0.72 |
-7 | 14 (11.4%) | 4 (11.8%) | 1.00 |
+8 | 22 (17.9%) | 9 (22.6%) | 0.27 |
20q- | 20 (16.3%) | 2 (5.9%) | 0.17 |
-Y | 5 (4.1%) | 0 (0%) | 0.59 |